Long‐Term Adherence and Drug Utilisation Patterns Among New Users of Anti‐Hyperlipidemic Monotherapy: Development of a Risk Prediction Model

Simvastatin users demonstrated higher adherence and continuation rates compared to other anti-hyperlipidemic monotherapy users. Factors including older age, female sex, and diabetes medications use were associated with improved adherence. Sensitivity analyses using equivalent dosing regimens yielded consistent findings. These insights into adherence and drug patterns are critical for informing personalised strategies to optimise cardiovascular disease prevention.